#

Dailypharm Live Search Close
  • New drug pre-registration - post-evaluation non-face-to-face
  • by Lee, Jeong-Hwan | translator Kim, Jung-Ju | 2023-06-22 05:41:03
Disclosure of the direction of the Ministry of Health and Welfare and the Ministry of Health and Welfare
Ho-Jun Son, Manager, “I will put my concerns about new drugs and medical technologies, and an innovative health insurance system”

The government plans to include discussions on the need to apply innovative insurance systems such as new drugs and new medical technology 'seondeungjae-postevaluation' to strengthen treatment coverage for severe diseases such as cancer in the '2nd National Health Insurance Comprehensive Plan' to be established in the second half of this year.

 

The purpose is to draw a blueprint for the future in which a sustainable health insurance policy to supply new drugs and new medical technologies to the people in a timely manner can be discussed at the social consensus body.

 

In particular, it also revealed the direction that measures to activate home medical treatment and institutionalize non-face-to-face treatment will inevitably be included in the 2nd comprehensive health insurance plan to establish a health care policy that goes beyond time and space constraints.

 

The Ministry of Health and Welfare and KIHASA, which initiated the establishment of the 2nd health insurance plan, made this announcement on the 19th at the 'policy debate for health insurance reform desired by the people hosted by Lee Jong-Seong, a member of the People's Power, and hosted by the Future Health Network.

 

On this day, the results of a public awareness survey on national health insurance conducted with 5,000 people across the country were released.

 

As a result of the survey, 85% of the respondents agreed to strengthen the guarantee of new drugs and new medical technologies for the treatment of severe diseases such as cancer or rare diseases.

 

Shin Hyun-woong, a senior research fellow at the National Health Insurance Institute, who is in charge of research on the 2nd health insurance comprehensive plan, revealed the direction of the comprehensive health insurance plan.

 

Researcher Shin Hyeon-wrong explained that although the details cannot be mentioned in detail as the research is still in progress, the outline of the health insurance plan set up by the Yoon government will be partially disclosed.

 

Commissioner Shin said that the 2nd Comprehensive Health Insurance Plan would take a different direction than the previous administration, which focused on increasing the coverage rate by resolving economic accessibility.

 

It was said that the 2nd Comprehensive Plan would contain not only economic feasibility, but also concerns about medical coverage policies that transcend time, space, geography, and service constraints anytime, anywhere.

 

Commissioner Shin cited home medical services and institutionalization of non-face-to-face medical treatment as representative examples.

 

In particular, he said that he would include in the research the health insurance pre-registration and post-evaluation policies for new drugs and new medical technologies, along with measures to resolve the current fee-for-service fee system limitations.

 

Commissioner Shin said, "Currently, the people's medical need is high, but there is a problem that the medical service itself is not created.

 

The essential medical vacuum comes out when you turn on the news." "We will provide medical guarantees that go beyond the limits of time and space.

 

For a health care policy that resolves time and space constraints, home medical care and non-face-to-face care have no choice but to be dealt with," he explained.

 

Commissioner Shin said, “The higher the frequency of the fee-for-service system, the higher the profit.

 

The lower the investment, the lower the investment.” We are thinking about reorganizing the payment system," he added.

 

Commissioner Shin said, "In terms of coverage, we will cover not only treatment but also prevention and health care, as well as mental health.

 

We are considering a system that preemptively guarantees medical safety net funds, anticancer drugs, and expensive drugs for rare diseases." I am doing it," he said.

 

Son Ho-Joon, head of the insurance policy department at the Ministry of Health and Welfare, also announced that he would establish a second health insurance plan to create a structure in which the health insurance system plays a role in ensuring people's medical care.

 

He also said that he would improve the problem of financial leakage, and discuss the registration of health insurance for anticancer drugs, rare disease treatments, and innovative medical technologies and medical practices.

 

Manager Son Ho-Joon said, "We plan to establish a second health care plan that includes not only the financial sustainability of health insurance but also the reason for the existence of the health insurance system." A representative case is to catch the unnecessary leakage of finance and invest in essential childbirth and pediatric medical care.” Manager Son said, "In addition to this short-term approach, a structural and health insurance approach is included in the comprehensive plan.

 

We will also discuss the issue of the payment system and enter into it to ensure the people's essential medical care." It also includes discussing the application of an innovative insurance system for new drugs and new medical technologies to enable the continuous supply of medical services while looking at whether they will play a role.”

 

  • 0
Reader Comment
0
Member comment Write Operate Rule
Colse

댓글 운영방식은

댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.

댓글 노출방식은

댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.

댓글의 삭제 기준은

다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.

  • 저작권·인격권 등 타인의 권리를 침해하는 경우

    상용 프로그램의 등록과 게재, 배포를 안내하는 게시물

    타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물

  • 근거 없는 비방·명예를 훼손하는 게시물

    특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우

    특정 지역 및 종교간의 감정대립을 조장하는 내용

    사실 확인이 안된 소문을 유포 시키는 경우

    욕설과 비어, 속어를 담은 내용

    정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)

    특정 지역이나 단체를 비하하는 경우

    특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우

    특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우

    타인의 ID 혹은 닉네임을 도용하는 경우

  • 게시판 특성상 제한되는 내용

    서비스 주제와 맞지 않는 내용의 글을 게재한 경우

    동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우

    부분적으로 변경하여 반복 게재하는 경우도 포함

    제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우

    돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물

    게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우

  • 수사기관 등의 공식적인 요청이 있는 경우

  • 기타사항

    각 서비스의 필요성에 따라 미리 공지한 경우

    기타 법률에 저촉되는 정보 게재를 목적으로 할 경우

    기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용

  • 사실 관계 확인 후 삭제

    저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우

    타인의 초상권을 침해하거나 개인정보를 유출하는 경우

    당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)

  • ※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.

    ※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.

    ※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.

If you want to see the full article, please JOIN US (click)